Depletion of nucleophosmin via transglutaminase 2 cross-linking increases drug resistance in cancer cells

Cancer Letters

Volumn 274, Issue 2, 2009, Pages 201-207

  Park, Kang Seo ^a,b   Han, Byeong Gu ^a,c   Lee, Kyoung Hwa ^a   Kim, Dae Seok ^a,d   Kim, Jung Mo ^a   Jeon, Hyesung ^e   Kim, Hyoun Sook ^f   Suh, Se Won ^f   Lee, Eunjoo H ^g   Kim, Soo Youl ^a   Lee, Byung Il ^a  

^a National Cancer Center   (South Korea)

^b Kyung Hee University Hospital   (South Korea)

^c Sungkyunkwan University   (South Korea)

^d Sungkyunkwan University School of Medicine   (South Korea)

^e Korea Institute of Science and Technology   (South Korea)

^f Seoul National University   (South Korea)

^g Kyung Hee University   (South Korea)

Author keywords

B23; Drug resistance; Nucleophosmin; Polymerization; Transglutaminase

Indexed keywords

CYSTAMINE; DOXORUBICIN; NUCLEOPHOSMIN; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE 2; UBIQUITIN;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER RESISTANCE; CELL FRACTIONATION; CONTROLLED STUDY; CYTOSOL; ENZYME INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN POLYMERIZATION; PROTEIN STABILITY;

BIOPOLYMERS; CELL LINE, TUMOR; CHROMATOGRAPHY, LIQUID; DRUG RESISTANCE, NEOPLASM; GTP-BINDING PROTEINS; HUMANS; MASS SPECTROMETRY; MICROSCOPY, ELECTRON, TRANSMISSION; NUCLEAR PROTEINS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TANDEM MASS SPECTROMETRY; TRANSGLUTAMINASES;

EID: 58149463059     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2008.09.007     Document Type: Article

References (35)

1. Folk J.E., and Chung S.I. Transglutaminases. Methods Enzymol. 113 (1985) 358-375
2. Ichinose A. Physiopathology and regulation of factor XIII. Thromb. Haemost. 86 (2001) 57-65
3. Aeschlimann D., and Thomazy V. Protein crosslinking in assembly and remodelling of extracellular matrices: the role of transglutaminases. Connect. Tissue Res. 41 (2000) 1-27
4. Akimov S.S., and Belkin A.M. Cell surface tissue transglutaminase is involved in adhesion and migration of monocytic cells on fibronectin. Blood 98 (2001) 1567-1576
5. Steinert P.M. The complexity and redundancy of epithelial barrier function. J. Cell Biol. 151 (2000) F5-F8
6. Fesus L., Thomazy V., and Falus A. Induction and activation of tissue transglutaminase during programmed cell death. FEBS Lett. 224 (1987) 104-108
7. Mehta K. High levels of transglutaminase expression in doxorubicin-resistant human breast carcinoma cells. Int. J. Cancer 58 (1994) 400-406
8. Mehta K., Fok J., Miller F.R., Koul D., and Sahin A.A. Prognostic significance of tissue transglutaminase in drug resistant and metastatic breast cancer. Clin. Cancer Res. 10 (2004) 8068-8076
9. Antonyak M.A., Miller A.M., Jansen J.M., Boehm J.E., Balkman C.E., Wakshlag J.J., Page R.L., and Cerione R.A. Augmentation of tissue transglutaminase expression and activation by epidermal growth factor inhibit doxorubicin-induced apoptosis in human breast cancer cells. J. Biol. Chem. 279 (2004) 41461-41467
10. Lee J., Kim Y.S., Choi D.H., Bang M.S., Han T.R., Joh T.H., and Kim S.Y. Transglutaminase 2 induces nuclear factor-kappaB activation via a novel pathway in BV-2 microglia. J. Biol. Chem. 279 (2004) 53725-53735
11. Kim D.S., Park S.S., Nam B.H., Kim I.H., and Kim S.Y. Reversal of drug resistance in breast cancer cells by transglutaminase 2 inhibition and nuclear factor-kappaB inactivation. Cancer Res. 66 (2006) 10936-10943
12. Feuerstein N., and Mond J.J. Identification of a prominent nuclear protein associated with proliferation of normal and malignant B cells. J. Immunol. 139 (1987) 1818-1822
13. Schmidt-Zachmann M.S., Hügle-Dörr B., and Franke W.W. A constitutive nucleolar protein identified as a member of the nucleoplasmin family. EMBO J. 6 (1987) 1881-1890
14. Schmidt-Zachmann M.S., and Franke W.W. DNA cloning and amino acid sequence determination of a major constituent protein of mammalian nucleoli correspondence of the nucleoplasmin-related protein NO38 to mammalian protein B23. Chromosoma 96 (1988) 417-426
15. Chan W.Y., Liu Q.R., Borjigin J., Busch H., Rennert O.M., Tease L.A., and Chan P.K. Characterization of the cDNA encoding human nucleophosmin and studies of its role in normal and abnormal growth. Biochemistry 28 (1989) 1033-1039
16. Colombo E., Marine J.C., Danovi D., Falini B., and Pelicci P.G. Nucleophosmin regulates the stability and transcriptional activity of p53. Nat. Cell Biol. 4 (2002) 529-533
17. Wu M.H., Chang J.H., and Yung B.Y. Resistance to UV-induced cell-killing in nucleophosmin/B23 over-expressed NIH 3T3 fibroblasts: enhancement of DNA repair and up-regulation of PCNA in association with nucleophosmin/B23 over-expression. Carcinogenesis 23 (2002) 93-100
18. Colombo E., Bonetti P., Lazzerini Denchi E., Martinelli P., Zamponi R., Marine J.C., Helin K., Falini B., and Pelicci P.G. Nucleophosmin is required for DNA integrity and p19Arf protein stability. Mol. Cell. Biol. 25 (2005) 8874-8886
19. Grisendi S., Mecucci C., Falini B., and Pandolfi P.P. Nucleophosmin and cancer. Nat. Rev. Cancer 6 (2006) 493-505
20. Morris S.W., Kirstein M.N., Valentine M.B., Dittmer K., Shapiro D.N., Look A.T., and Saltman D.L. Fusion of a kinase gene, ALK, to a nucleolar protein gene, NUCLEOPHOSMIN, in non-Hodgkin's lymphoma. Science 267 (1995) 316-317
21. Redner R.L., Rush E.A., Faas S., Rudert W.A., and Corey S.J. The t(5;17) variant of acute promyelocytic leukemia expresses a nucleophosmin-retinoic acid receptor fusion. Blood 87 (1996) 882-886
22. Yoneda-Kato N., Look A.T., Kirstein M.N., Valentine M.B., Raimondi S.C., Cohen K.J., Carroll A.J., and Morris S.W. The t(3;5)(q25.1;q34) of myelodysplastic syndrome and acute myeloid leukemia produces a novel fusion gene NPM-MLF1. Oncogene 12 (1996) 265-275
23. Kerr L.E., Birse-Archbold J.L., Short D.M., McGregor A.L., Heron I., Macdonald D.C., Thompson J., Carlson G.J., Kelly J.S., McCulloch J., and Sharkey J. Nucleophosmin is a novel Bax chaperone that regulates apoptotic cell death. Oncogene 26 (2007) 2554-2562
24. Park S.S., Kim D.S., Park K.S., Song H.J., and Kim S.Y. Proteomic analysis of high-molecular-weight protein polymers in a doxorubicin-resistant breast-cancer cell line. Proteomics Clin. Appl. 1 (2007) 555-560
25. Szebeni A., and Olson M.O. Nucleolar protein B23 has molecular chaperone active ties. Protein Sci. 8 (1999) 905-912
26. Kim S.Y. Transglutaminase 2 in inflammation. Front Biosci. 11 (2006) 3026-3035
27. Hingorani K., Szebeni A., and Olson M.O. Mapping the functional domains of nucleolar protein B23. J. Biol. Chem. 275 (2000) 24451-24457
28. Eifert C., Burgio M.R., Bennett P.M., Salerno J.C., and Koretz J.F. N-terminal control of small heat shock protein oligomerization: changes in aggregate size and chaperone-like function. Biochim. Biophys. Acta 1748 (2005) 146-156
29. Herman J.F., Mangala L.S., and Mehta K. Implications of increased tissue transglutaminase (TG2) expression in drug-resistant breast cancer (MCF-7) cells. Oncogene 25 (2006) 3049-3058
30. Lee H.Z., Wu C.H., and Chang S.P. Release of nucleophosmin from the nucleus: involvement in aloe-emodin-induced human lung non small carcinoma cell apoptosis. Int. J. Cancer 113 (2005) 971-976
31. Verma A., Guha S., Wang H., Fok J.Y., Koul D., Abbruzzese J., and Mehta K. Tissue transglutaminase regulates focal adhesion kinase/AKT activation by modulating PTEN expression in pancreatic cancer cells. Clin. Cancer Res. 14 (2008) 1997-2005
32. Chandra D., Choy G., and Tang D.G. Cytosolic accumulation of HSP60 during apoptosis with or without apparent mitochondrial release: evidence that its pro-apoptotic or pro-survival functions involve differential interactions with caspase-3. J. Biol. Chem. 282 (2007) 31289-31301
33. Orrù S., Caputo I., D'Amato A., Ruoppolo M., and Esposito C. Proteomics identification of acyl-acceptor and acyl-donor substrates for transglutaminase in a human intestinal epithelial cell line implications for celiac disease. J. Biol. Chem. 278 (2003) 31766-31773
34. Han J.A., and Park S.C. Reduction of transglutaminase 2 expression is associated with an induction of drug sensitivity in the PC-14 human lung cancer cell line. J. Cancer Res. Clin. Oncol. 125 (1999) 89-95
35. Verma A., Wang H., Manavathi B., Fok J.Y., Mann A.P., Kumar R., and Mehta K. Increased expression of tissue transglutaminase in pancreatic ductal adenocarcinoma and its implications in drug resistance and metastasis. Cancer Res. 66 (2006) 10525-10533